HHS.gov @HHSGov
HHS and @DeptofDefense also announced an agreement with @Regeneron to demonstrate commercial-scale manufacturing of the company’s #COVID19 investigational anti-viral antibody treatment, REGN-COV2. [3/3] https://t.co/MvqI5yxYTf — PolitiTweet.org